Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label 52-Week Safety Study of Bicifadine SR in Adult Outpatients With Chronic Peripheral Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

NCT00597649 is registered in ClinicalTrials.gov with XTL Biopharmaceuticals as lead sponsor.

NCT NCT00597649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00597649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label 52-Week Safety Study of Bicifadine SR in Adult Outpatients With Chronic Peripheral Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Lead sponsor
XTL Biopharmaceuticals
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2007
Completion date
December 31, 2008
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic peripheral neuropathy pain in diabetics